Why the study?
Hypertriglyceridemic acute pancreatitis is an emerging issue that is frequently underdiagnosed in clinical practice, making accurate diagnosis crucial for appropriate treatment and recurrence risk reduction.
Hypertriglyceridemia is an important, frequently underdiagnosed cause of acute pancreatitis that requires accurate diagnosis to establish appropriate treatment and reduce recurrence risk.
Answers are grounded in this paper and cite their sources.
Hypertriglyceridemia warrants consideration in acute pancreatitis; leaves open optimal management pending prospective validation.
Hypertriglyceridemic acute pancreatitis is an emerging issue in gastroenterology, frequently underdiagnosed in clinical practice. Despite the rarity of the disease, hypertriglyceridemia should be considered as a leading cause of acute pancreatitis, especially in defined subsets of patients. Primary and secondary forms of hypertriglyceridemia need to be considered and excluded during the diagnostic work-up of all patients with acute pancreatitis. An accurate diagnosis is crucial to establish an appropriate treatment and to reduce the risk of recurrences. The aim of the present article is to briefly review epidemiology, etiology, diagnosis and therapy of hypertriglyceridemic acute pancreatitis, based on a clinical and practical point of view.
No takes yet. Share an insight, caveat, or question.
Pretis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: